Advarra Technology Used by Academic Institutions During COVID-19
April 14, 2020
Applied Clinical Trials
Advarra updated progress it has made with academic institutions in regard to the company’s technology use in academic institutions. The update includes the following:
Henry Ford Health System is implementing Advarra’s Forte EDC under an accelerated two-week timeline to fast track the activation of its COVID-19 trial.
Advarra’s eRegulatory management system, Forte eReg, is being used to ensure regulatory compliance and remote access to regulatory info, by academic institutions, including Karmanos Cancer Institute.
Advarra worked with Yale University to identify a streamlined approach to study activation, monitoring, and reporting for its COVID-19 studies leveraging Advarra’s OnCore Enterprise Research System and its Forte Insights analytics platform.